Inhibition of CYP1B1 by TMS reduced blood pressure, decreased vascular reactivity, cardiovascular hypertrophy, endothelial and renal dysfunction, and cardiac and renal fibrosis. Here, CYP1B1 is linked to renal fibrosis.